Dear Sir, Smartphone-based image acquisition is increasingly becoming popular in the field of ophthalmology. Higher resolution camera applications have made it possible to acquire high-definition images of the anterior segment, posterior segment, and the periocular lesions with great ease and at a lesser cost. We have described a few techniques of the anterior segment and optic disc image acquisition using a smartphone-macro lens combination (a small, magnifying lens attachment called the macro lens, no financial interest). [1, 2] The cost of this lens is less than 2USD, and using this lens we were able to acquire high-resolution images. These are very simple techniques that help in a better appreciation of the finer details of the cornea, iris, retina, and the optic nerve head (for retina and the disc 90D lens is additionally used). In addition, we also highlighted the utility of this technique for the quantification of the iris torsion. [3] Using an unmodified iPhone X, Gunasekera et al. have described on how to capture the images of optic disc. [4] We also performed an observation using unmodified iPhone X and found that the image qualities obtained by this technique are also of good quality. In addition, the details of the peripapillary area and the macula can also be better appreciated; however, this has been lacking in the previous observation by Gunasekera et al. [ Fig. 1a and b]. Therefore, this expands the existing knowledge regarding the utility of unmodified iPhone X just to image the optic disc.
As significant ocular pathologies along disc, macula, and the peripapillary area can be documented with greater ease in one frame, the unmodified iPhone X can be helpful in imaging the major posterior pole retinal diseases. Therefore, the resident ophthalmologists and other practitioners can adopt these techniques and further refine them to maximize the utility of smartphone-based imaging technology in ophthalmology. This, in turn, helps in saving precious time in busy clinics to serve the patients better. Dear Sir, We read with great interest the article by Majumder et al., [1] titled "Clinical profile of uveitis patients developing central serous chorioretinopathy: An experience at a tertiary eye care center in India." In this paper, the authors have described the demographic and clinical features of central serous chorioretinopathy (CSCR) in eyes with previously diagnosed cases of uveitis. However, we have a few comments to make.
The two main factors responsible for the development of CSCR in uveitic patients are use of long-term corticosteroids (all routes) [2, 3] and inflammation itself leading to the breakdown of the blood-retinal barrier and increased choroidal hyperpermeability. Also, in cases of long-standing uveitis, the retinal pigment epithelium becomes dysfunctional leading to the poor absorption of the overlying subretinal fluid. With these mechanisms in mind, the authors have not addressed certain important aspects regarding the disease in their methodology or discussion. There is no mention in the paper regarding the mean duration of corticosteroid usage for developing CSCR, presence of unilateral/bilateral uveitis, whether the CSCR affected the same eye as the uveitis or fellow eye, was the uveitis active/inactive at the time of development of CSCR, and was the patient a known case of CSCR before the development of uveitis. All these factors are important and would play an important role in deciding the management of both uveitis and CSCR. Also, the presence of multiple leaks on fluorescein angiography could confuse other conditions like Vogt-Koyanagi-Harada syndrome, sympathetic ophthalmia, and posterior scleritis with CSCR. [4] Identification of pigment epithelial detachment on optical coherence tomography would tilt the diagnosis more in favor of CSCR in cases of dilemma.
Hence, to conclude, the presence of CSCR in uveitic eyes is always challenging in terms of diagnosis and formulating treatment strategy for both uveitis and CSCR.
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